OTC Labeling Reg Deferral For Convenience Size OTCs To Be Issued By FDA
This article was originally published in The Rose Sheet
Executive Summary
FDA will publish a notice to "delay the compliance date of the current Drug Facts rules with respect to 'convenience-size' drug packages" in an upcoming issue of the Federal Register, the agency says in a recent letter to Lil' Drug Store Products
You may also be interested in...
“Convenience-Size” OTCs Inner Package Labeling Limits Supported
FDA limits on the information that must appear on the inner package of one- and two-dose size OTC drugs are supported by drug relabeler Mechanical Servants in May 13 comments to the agency
“Convenience-Size” OTCs Inner Package Labeling Limits Supported
FDA limits on the information that must appear on the inner package of one- and two-dose size OTC drugs are supported by drug relabeler Mechanical Servants in May 13 comments to the agency
“Drug Facts” Consumer Understanding Dependant On Education – FDA
FDA is confident OTC "Drug Facts" labeling will help consumers use nonprescription drugs appropriately, but the agency also is stressing the importance of educational initiatives in ensuring proper use